These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 25226477

  • 1. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.
    JAMA; 2014 Sep 17; 312(11):1114-21. PubMed ID: 25226477
    [Abstract] [Full Text] [Related]

  • 2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 17; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 3. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, Stukel T.
    Ann Intern Med; 2011 May 03; 154(9):583-92. PubMed ID: 21536937
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 03; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 5. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Apr 03; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.
    JAMA Intern Med; 2013 Jul 08; 173(13):1175-85. PubMed ID: 23689820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients.
    Soriano JB, Kiri VA, Pride NB, Vestbo J.
    Am J Respir Med; 2003 Jul 08; 2(1):67-74. PubMed ID: 14720023
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.
    Rodrigo GJ, Castro-Rodriguez JA, Plaza V.
    Chest; 2009 Oct 08; 136(4):1029-1038. PubMed ID: 19633090
    [Abstract] [Full Text] [Related]

  • 12. Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events.
    Patel HC, Hayward C, Patel KS, Claggett B, Vazir A, Cowie MR.
    Int J Cardiol; 2020 Feb 01; 300():237-244. PubMed ID: 31813679
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD, Johnson M, Gan WQ, Man SF.
    Curr Pharm Des; 2004 Feb 01; 10(28):3547-60. PubMed ID: 15579052
    [Abstract] [Full Text] [Related]

  • 14. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK, Hartzema AG, Winterstein AG, Segal R, Lu X, Hendeles L.
    Value Health; 2015 Mar 01; 18(2):260-70. PubMed ID: 25773561
    [Abstract] [Full Text] [Related]

  • 15. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 01; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 16. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC, Hurst MM.
    Pharmacol Ther; 2011 May 01; 130(2):114-43. PubMed ID: 21276815
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
    Nannini LJ, Cates CJ, Lasserson TJ, Poole P.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD006829. PubMed ID: 17943918
    [Abstract] [Full Text] [Related]

  • 19. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY.
    PLoS One; 2015 Oct 17; 10(7):e0130102. PubMed ID: 26158649
    [Abstract] [Full Text] [Related]

  • 20. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH, Chang CH, Gagne JJ, Hsu CL, Lai MS.
    Pharmacotherapy; 2016 Jan 17; 36(1):26-37. PubMed ID: 26799347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.